<--- Back to Details
First PageDocument Content
Chemotherapy / Oncology / Anthracycline / Cancer / Leukemia / Breast cancer / Prostate cancer / Mitotic inhibitor / Discovery and development of tubulin inhibitors / Medicine / Cancer treatments / Ribbon symbolism
Date: 2014-04-09 16:37:48
Chemotherapy
Oncology
Anthracycline
Cancer
Leukemia
Breast cancer
Prostate cancer
Mitotic inhibitor
Discovery and development of tubulin inhibitors
Medicine
Cancer treatments
Ribbon symbolism

Chemo Tools Guide Breast Cancer

Add to Reading List

Source URL: guide2chemo.com

Download Document from Source Website

File Size: 54,37 KB

Share Document on Facebook

Similar Documents

Practice Based Evidence for Treatment of Pregnancy and Anthracycline Cardiomyopathy JEAN-BERNARD DURAND, M.D., FCCP, FACC,FACP,FHFSA,FAHA PROFESSOR OF MEDICINE

DocID: 1vjaw - View Document

Lymphoma / Lymphoma in animals / CHOP / B-cell chronic lymphocytic leukemia / Doxorubicin / Anthracycline / Chemotherapy / Vincristine / VAMP Regimen / Medicine / Oncology / Chemotherapy regimens

Rescue therapy with doxorubicin-based chemotherapy for relapsing or refractory feline lymphoma: a retrospective study of 23 cases

DocID: 18tI1 - View Document

Enantiopure drugs / Anthracycline / Ribbon symbolism / Dexrazoxane / Chemotherapy regimens / Epirubicin / Metastatic breast cancer / Breast cancer / Medicine / Chemistry / Oncology

2?-JUN-241.L DEPT OF HERLTH 1_6129

DocID: 11ddA - View Document

Lactones / Statins / Oncology / Lovastatin / Doxorubicin / Alcohols / HMG-CoA reductase / Chemotherapy / Daunorubicin / Medicine / Anthracyclines / Chemistry

Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity

DocID: 10307 - View Document

Adjuvant therapy / Trastuzumab / Chemotherapy / Breast cancer / Epirubicin / Radiation therapy / Fluorouracil / Metastatic breast cancer / Breast cancer chemotherapy / Medicine / Cancer treatments / Chemotherapy regimens

Vol. 7, 1577–1581, June[removed]Clinical Cancer Research 1577 Chemotherapy Response of Breast Cancer Depends on HER-2 Status and Anthracycline Dose Intensity in the

DocID: 102XV - View Document